BridgeMD
New treatment option for Post-Acne Atrophic Scars
Official title PRP Plus Fractional CO₂ Laser for Acne Scars
ClinicalTrials.gov ID: NCT07352215
What this study is testing
- What it's testing
- This randomized controlled trial aims to evaluate whether adding platelet-rich plasma (PRP) to fractional CO₂ laser resurfacing improves the treatment of moderate-to-severe acne scars compared with laser alone. Seventy adults aged 18-40 years will be recruited from the Dermatology Department of Gujranwala Medical College Teaching Hospital.
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 40
You may be able to join if
- Adults aged 18 to 40 years
- Male and female participants
- Fitzpatrick skin types I to V
- Presence of moderate-to-severe acne scars
- Willing to undergo 3 treatment sessions and follow-up visits
You likely can't join if
- Use of topical anti-acne medications in the past 1 month
- History of keloid formation or hypertrophic scarring
- Active acne or active skin inflammation at treatment area
- Diabetes mellitus
- Photosensitive disorders (e.g., lupus, dermatomyositis)
- Melasma
See the full eligibility criteria
- Adults aged 18 to 40 years
- Male and female participants
- Fitzpatrick skin types I to V
- Presence of moderate-to-severe acne scars
- Willing to undergo 3 treatment sessions and follow-up visits
- Able to provide informed consent -
- Use of topical anti-acne medications in the past 1 month
- History of keloid formation or hypertrophic scarring
- Active acne or active skin inflammation at treatment area
- Diabetes mellitus
- Photosensitive disorders (e.g., lupus, dermatomyositis)
- Melasma
- Active infections (e.g., Herpes simplex)
- Recent laser resurfacing or similar procedures
- Outdoor workers with high sun exposure
- Vitiligo
- Pregnancy or breastfeeding
- Bleeding disorders or anticoagulant therapy
- Unrealistic expectations or inability to comply with follow-up
The study team makes the final eligibility decision.
Where it's taking place
- Gujranwala, Punjab Province, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 40 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Gujranwala, Punjab Province, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.